Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Bioventix PLC

BVXP.L ✓ COMPLIANT ☆ Track — members

LSE · Healthcare · Biotechnology & Medical Research ·

UK Micro Cap Analyst: N/A

Last Close

$23.39

▲ +0.00%

Market Cap $121.88M · Vol 5.57K

Key Metrics

P/E Ratio

12.23

FWD: N/A

Market Cap

$121.88M

Micro Cap

Div Yield

8.67%

Semi-annual dividend

EPS Growth

-6.16%

YoY

RSI (14)

80.26

Momentum

Beta

0.35

vs Market

52W High

$34.48

32.35% below

52W Low

$17.58

33.63% above

Volume

5.57K

Avg 9.47K

P/B

12.44

Price-to-book

ROE

N/A

Return on equity

Free Float

80.28%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Bioventix PLC (BVXP.L) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does BVXP.L pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+0.00%

+14.57%

+4.22%

+19.31%

YTD

-9.19%

-29.96%

-51.10%

-57.99%

Financials & Valuation

TTM · Annual

Total Revenue	$18.01M
Net Income	$10.42M
Revenue Growth (YoY)	-8.52%
Gross Margin	90.86%
Operating Margin	74.54%
Net Profit Margin	57.83%
ROE	N/A
ROA · ROIC	75.92% · 64.40%

P/E Ratio	12.23
Forward P/E (FY1)	N/A
PEG Ratio	-3.82
P/S	10.95
P/B	12.44
P/FCF	19.93
EPS Growth	-6.16%
Outstanding Shares	5.22M

Technical Indicators

50-Day SMA	$21.60
200-Day SMA	$22.75
RSI (14)	80.26
Beta	0.35
52-Week High	$34.48
52-Week Low	$17.58

Volume Today	5.57K
Avg Daily Volume (30D)	9.47K
Relative Volume	0.59x
Volatility (10D)	14.01
Volatility (30D)	31.21
Free Float	80.28%

Analyst Consensus

N/A

Current Price $23.39

Mean Target $52.01

52W Low$17.58 52W High$34.48

Current

Target

$17.58 $34.48

Current Analyst target

+122.33% upside potential · 1 analysts

Identifiers

ExchangeLSE

FIGIBBG001T7VPR1

ISINGB00B4QVDF07

CountryUnited Kingdom

Sub-IndustryBiotechnology & Medical Research (NEC)

Earnings DateOct 26, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LONN.S Lonza Group AG -0.24% RVMD Revolution Medicines Inc +0.78% ONC BeOne Medicines AG +0.25% 068270.KS Celltrion Inc +0.43% ABVX Abivax SA +2.66%

Company Profile

Bioventix plc is a United Kingdom-based company specializing in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, such as automated immunoassays used in blood testing. The antibodies created at the Company are generated in sheep and are of particular benefit where the target is present at low concentration and where conventional monoclonal or polyclonal antibodies have failed to produce a suitable reagent. It offers a portfolio of antibodies to customers for both commercial use and research and development purposes, for the diagnosis or monitoring of a range of conditions, including heart disease, cancer, fertility, thyroid function and drug abuse. The Company’s products include sheep monoclonal antibodies (SMAs), Pyrene (HOP-G) ELISA Kits, and Pyrene (HOP-G) Lateral Flow Kits. The Company supplies antibody products and services to the majority of multinational clinical diagnostics companies.